Abstract:Targeted delivery to the diseased cell or tissue is the key to the successful clinical use of nucleic acid drugs. In particular, delivery of microRNA-140 (miRNA-140, miR-140) into chondrocytes across the dense, nonvascular extracellular matrix of cartilage remains a major challenge. Here, we report the chondrocyte-targeting exosomes as vehicles for the delivery of miR-140 into chondrocytes as a new treatment for osteoarthritis (OA). By fusing a chondrocyte-affinity peptide (CAP) with the lysosome-associated membrane glycoprotein 2b protein on the surface of exosomes, we acquire CAP-exosomes that can efficiently encapsulate miR-140, specifically enter, and deliver the cargo into chondrocytes in vitro. CAP-exosomes, in contrast to nontagged exosome vesicles, are retained in the joints after intra-articular injection with minimal diffusion in vivo. CAP-exosomes also deliver miR-140 to deep cartilage regions through the dense mesochondrium, inhibit cartilage-degrading proteases, and alleviate OA progression in a rat model, pointing toward a potential organelle-based, cell-free therapy of OA.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c10458?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c10458</a>.List of primers used for cloning, reverse transcription-polymerase chain reaction (RT-PCR), and real-time quantitative RT-PCR in this work; list of antibodies used in this work; overexpression of GFP-Lamp2b or CAP-GFP-Lamp2b in dendritic cells showing green puncta; selective entrance of CAP-GFP-exosomes to chondrocytes but not SF-MSCs; quantification of the loading efficiency of exosomes; CAP-exosomes showed increased delivery of miRNA-140 to chondrocytes than exosomes without the CAP signal; analysis of the reporter gene activity in chondrocytes confirms that CAP-exosome/miR-140 directly targets the predicted binding sites in the MMP-13 and Adamts-5 3′UTR; images of safranin O and fast green staining of cartilages under different treatments; and toxicity of the exosome treatment to major organs (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c10458/suppl_file/am0c10458_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

CKIP-1-Loaded Cartilage-Affinitive Nanoliposomes Reverse Osteoarthritis by Restoring Chondrocyte Homeostasis.

Reactivation of NR4A1 Restrains Chondrocyte Inflammation and Ameliorates Osteoarthritis in Rats

Cartilage-Targeting Mrna-Lipid Nanoparticles Rescue Perifocal Apoptotic Chondrocytes for Integrative Cartilage Repair

Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment.

A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis

Targeting FAP-positive chondrocytes in osteoarthritis: a novel lipid nanoparticle siRNA approach to mitigate cartilage degeneration

Promoting chondrogenesis by targeted delivery to the degenerating cartilage in early treatment of osteoarthritis

Chondroprotective Effects of Hyaluronic Acid-Chitosan Nanoparticles Containing Plasmid DNA Encoding Cytokine Response Modifier A in a Rat Knee Osteoarthritis Model

A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system

Disruption of phosphoinositide-specific phospholipases Cγ1 contributes to extracellular matrix synthesis of human osteoarthritis chondrocytes.

Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration

Ginsenoside Compound K Ameliorates Osteoarthritis by Inhibiting the Chondrocyte Endoplasmic Reticulum Stress-Mediated IRE1α-TXNIP-NLRP3 Axis and Pyroptosis

Precise targeting of miR-141/200c cluster in chondrocytes attenuates osteoarthritis development

Chondrocyte-Targeted Delivery System of Sortase A-Engineered Extracellular Vesicles Silencing MMP13 for Osteoarthritis Therapy

Chondrocyte-Targeted MicroRNA Delivery by Engineered Exosomes toward a Cell-Free Osteoarthritis Therapy

Inhibition of cc chemokine receptor 10 ameliorates osteoarthritis via inhibition of the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin pathway

High-Efficiency Treatment for Osteoarthritis Via Self-Assembled Dual-Functionalized Nanobiologics.

PLCγ1 Inhibition‐driven Autophagy of IL‐1β‐treated Chondrocyte Confers Cartilage Protection Against Osteoarthritis, Involving AMPK, Erk and Akt

Lipoxin A4 modulates the PKA/CREB and NF-κB signaling pathway to mitigate chondrocyte catabolism and apoptosis in temporomandibular joint osteoarthritis

Chondrocyte Membrane–coated Nanoparticles Promote Drug Retention and Halt Cartilage Damage in Rat and Canine Osteoarthritis

Cationic Solid Lipid Nanoparticles Loaded by Integrin &#x3b2;1 Plasmid DNA Attenuates IL-1&#x3B2;-induced Apoptosis of Chondrocyte